rxstat › Shortages › Gabapentin

Gabapentin shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Gabapentin products are in shortage in Canada (24 of 78 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 11, 2026.
Products affected
24 of 78
In shortage since
Apr 11, 2014
Est. full return
Sep 11, 2026
Reports on file
233
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
GABAPENTIN
800MG · TABLET · JAMP PHARMA CORPORATION
DIN 02432080 · since May 12, 2026, est. end Sep 11, 2026 · Disruption of the manufacture of the drug.
Active shortage
GABAPENTIN
600MG · TABLET · JAMP PHARMA CORPORATION
DIN 02432072 · since Feb 26, 2026, est. end Sep 11, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-GABAPENTIN
600MG · TABLET · TEVA CANADA LIMITED
DIN 02248457 · since Feb 23, 2026, est. end Aug 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-GABAPENTIN
400MG · CAPSULE · TEVA CANADA LIMITED
DIN 02244515 · since Feb 23, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-GABAPENTIN
300MG · CAPSULE · TEVA CANADA LIMITED
DIN 02244514 · since Jun 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-GABAPENTIN
600MG · TABLET · APOTEX INC
DIN 02293358 · since Mar 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
NEURONTIN
800MG · TABLET · BGP PHARMA ULC
DIN 02239718 · since Jan 5, 2026, no end estimate · Shortage of an active ingredient.
Active shortage
APO-GABAPENTIN
800MG · TABLET · APOTEX INC
DIN 02293366 · since Feb 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
NEURONTIN
400MG · CAPSULE · BGP PHARMA ULC
DIN 02084287 · since Feb 2, 2026, no end estimate · Shortage of an active ingredient.
Active shortage
GABAPENTIN
800MG · TABLET · SANIS HEALTH INC
DIN 02431297 · since Aug 23, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
GABAPENTIN CAPSULES USP
400MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02416867 · since May 17, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
GABAPENTIN CAPSULES USP
100MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02416840 · since Jan 19, 2024, no end estimate · Requirements related to complying with good manufacturing practices.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Gabapentin is currently affected by 24 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, TEVA CANADA LIMITED, APOTEX INC, BGP PHARMA ULC and 6 others.

The reported causes are: disruption of the manufacture of the drug; shortage of an active ingredient; requirements related to complying with good manufacturing practices; delay in shipping of the drug; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Recent changes

Common questions

When will Gabapentin be back in stock in Canada?

The latest manufacturer estimate is Sep 11, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Gabapentin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs

Widespread shortageCaffeine Acetylsalicylic Acid Butalbital2 of 3 reported products affected · est. return Oct 20, 2026Partial shortageAcetaminophen9 of 26 reported products affected · est. return Jul 17, 2026Partial shortageAcetylsalicylic Acid5 of 17 reported products affectedPartial shortageCaffeine Acetylsalicylic Acid1 of 2 reported products affectedPartial shortagePregabalin19 of 79 reported products affected · est. return May 16, 2027DiscontinuedAcetaminophen Caffeine0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.